| Temporomandibular joint osteoarthritis: pathogenic mechanisms involving the cartilage and subchondral bone, and potential therapeutic strategies for joint regeneration A Cardoneanu, LA Macovei, AM Burlui, IR Mihai, I Bratoiu, II Rezus, ... International Journal of Molecular Sciences 24 (1), 171, 2022 | 33 | 2022 |
| Osteonecrosis of the femoral head in patients with hypercoagulability—from pathophysiology to therapeutic implications E Rezus, BI Tamba, MC Badescu, D Popescu, I Bratoiu, C Rezus International Journal of Molecular Sciences 22 (13), 6801, 2021 | 32 | 2021 |
| Adult-Onset Still’s Disease—A Complex Disease, a Challenging Treatment LA Macovei, A Burlui, I Bratoiu, C Rezus, A Cardoneanu, P Richter, ... International Journal of Molecular Sciences 23 (21), 12810, 2022 | 25 | 2022 |
| Targeting systemic sclerosis from pathogenic mechanisms to clinical manifestations: why IL-6? A Cardoneanu, AM Burlui, LA Macovei, I Bratoiu, P Richter, E Rezus Biomedicines 10 (2), 318, 2022 | 21 | 2022 |
| Why do we need JAK inhibitors in systemic lupus erythematosus? P Richter, A Cardoneanu, AM Burlui, LA Macovei, I Bratoiu, ... International Journal of Molecular Sciences 23 (19), 11788, 2022 | 18 | 2022 |
| The involvement of smooth muscle, striated muscle, and the myocardium in Scleroderma: a review I Bratoiu, AM Burlui, A Cardoneanu, LA Macovei, P Richter, G Rusu-Zota, ... International Journal of Molecular Sciences 23 (19), 12011, 2022 | 9 | 2022 |
| Current therapeutic approach to atrial fibrillation in patients with congenital hemophilia MC Badescu, OV Badulescu, LI Butnariu, M Floria, M Ciocoiu, II Costache, ... Journal of personalized medicine 12 (4), 519, 2022 | 9 | 2022 |
| Osteonecrosis of the jaws in patients with hereditary thrombophilia/hypofibrinolysis—from pathophysiology to therapeutic implications MC Badescu, E Rezus, M Ciocoiu, OV Badulescu, LI Butnariu, D Popescu, ... International Journal of Molecular Sciences 23 (2), 640, 2022 | 9 | 2022 |
| Interstitial Lung Disease in Systemic Lupus Erythematosus and Systemic Sclerosis: How Can We Manage the Challenge? P Richter, A Cardoneanu, N Dima, I Bratoiu, C Rezus, AM Burlui, D Costin, ... International Journal of Molecular Sciences 24 (11), 9388, 2023 | 2 | 2023 |
| Targeting Systemic Sclerosis from Pathogenic Mechanisms to Clinical Manifestations: Why IL-6? Biomedicines 2022, 10, 318 A Cardoneanu, AM Burlui, LA Macovei, I Bratoiu, P Richter, E Rezus Frontiers of Targeted Therapy and Predictors of Treatment Response in …, 2022 | 2 | 2022 |
| A Review of Anti-C Reactive Protein Antibodies in Systemic Lupus Erythematosus P Richter, A Burlui, I Bratoiu, A Cardoneanu, C Rezus, E Rezus Journal of Interdisciplinary Medicine 6 (2), 60-66, 2021 | 2 | 2021 |
| Autoimmunity and autoinflammation: relapsing polychondritis and VEXAS syndrome challenge A Cardoneanu, II Rezus, AM Burlui, P Richter, I Bratoiu, IR Mihai, ... International Journal of Molecular Sciences 25 (4), 2261, 2024 | 1 | 2024 |
| Digestive Dysbiosis in Systemic Scleroderma: A Review I Bratoiu, A Burlui, P Richter, A Cardoneanu, C Rezus, E Rezus Journal of Interdisciplinary Medicine 6 (2), 53-59, 2021 | 1 | 2021 |
| Paradoxical Psoriasis in Patients Receiving Therapy with Tumor Necrosis Factor Inhibitors: Potential Pathogenic Mechanisms and the Role of Genetic Factors D Costin, AM Burlui, A Cardoneanu, LA Macovei, C Rezus, I Bratoiu, ... International Journal of Molecular Sciences 25 (13), 7018, 2024 | | 2024 |
| The Lung in Rheumatoid Arthritis—Friend or Enemy? ML Anton, A Cardoneanu, AM Burlui, IR Mihai, P Richter, I Bratoiu, ... International Journal of Molecular Sciences 25 (12), 6460, 2024 | | 2024 |
| AB1177 CONNECTIONS BETWEEN EUSTAR–AI, GASTROINTESTINAL SYMPTOMS, AND NUTRITIONAL STATUS IN SCLERODERMA: A SINGLE CENTER PERSPECTIVE I Bratoiu, AM Burlui, E Rezus Annals of the Rheumatic Diseases 83 (Suppl 1), 1923-1923, 2024 | | 2024 |
| Autoimmune Liver Diseases and Rheumatoid Arthritis—Is There an Etiopathogenic Link? IR Mihai, C Rezus, MA Burlui, A Cardoneanu, LA Macovei, P Richter, ... International Journal of Molecular Sciences 25 (7), 3848, 2024 | | 2024 |
| P20 Interleukins as potential factors in assessing the disease activity in systemic lupus erythematosus P Richter, MA Burlui, CA Adam, I Bratoiu, VL Boiculese, E Rezus Lupus Science & Medicine 11 (Suppl 1), 2024 | | 2024 |
| AB1381 SLEEP QUALITY AND PAIN CHARACTERISTICS IN PATIENTS WITH RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS, AND OSTEOARTHRITIS MA Burlui, L Macovei, A Cardoneanu, DM Stincescu, A Codrianu, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 1920-1920, 2023 | | 2023 |
| SARS-CoV-2-induced myopathy: Clinical aspects, paraclinical changes, and therapeutic options. ML Loghinoaia, AM Burlui, A Cardoneanu, I Bratoiu, E Rezus Romanian Journal of Rheumatology 31 (4), 2022 | | 2022 |
